Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Maskapai Reasuransi Indonesia Tbk. (MREI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Maskapai Reasuransi Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Maskapai Reasuransi Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Maskapai Reasuransi Indonesia Tbk. trades at Rp920 (market cap 476.37B). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

LABSMREI
Market Cap
691.25B476.37B
Volume
635.5K
Lot
6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MREI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Maskapai Reasuransi Indonesia Tbk.

PT Maskapai Reasuransi Indonesia Tbk (the Company) was established on 4th June 1953 based on Notarial Deed No. 15 of Anton Frederik Schut a substitute of Meester Karel Esuard Krijgsman, notary in Jakarta.In 1998 PT. Dharmala Sakti Sejahtera became one of Marein’s major shareholders, besides AJB Bumiputera 1912, and as the result the company was able to increase its paid up capital to Rp 3,002,500,000.

Read more on MREI